Hepatitis C clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for

  • Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV

    Sorry, not yet accepting patients

    This is a Phase I/II, multi-site, open-label, single arm study to describe the pharmacokinetics (PK) and safety of glecaprevir/pibrentasvir (GLE/PIB) initiated during pregnancy in women with hepatitis C virus (HCV) infection (acute or chronic) with or without HIV and to evaluate safety for their infants through 10 weeks postpartum.

    Los Angeles, California and other locations

Last updated: